Tuesday, November 14, 2017

OncoSec Raises $9.3M Via Warrant Exercise

San Diego-based cancer immunotherapy developer OncoSec Medical says it has raised $9.3M via a warrant exercise agreement. The publicly traded company (NASDAQ: ONCS) said the deal allows holders of outstanding warrants to purchase up to 5,509,642 of its common stock at $1.69 per share. The company said the funds received in the warrant exercise will go towards working capital and general corporate purposes, a clinical trial, and other research and development. Names of the investors involved in the warrant exercise were not announced.